Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider

BACKGROUND: Acromegaly patients, even those with IGF-1 values within the normal range receiving somatostatin receptor ligands (SRLs), often suffer from significant symptoms. It is not known to what extent patients’ medical providers are aware of the frequency and severity of acromegaly symptoms or l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pituitary
Egile Nagusiak: Geer, Eliza B., Sisco, Jill, Adelman, Daphne T., Ludlam, William H., Haviv, Asi, Gelbaum, Dana, Liu, Shuqian, Mathias, Susan D., Shi, Lizheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066283/
https://ncbi.nlm.nih.gov/pubmed/31808101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-019-01013-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak